4155 — OK Biotech Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedSmall CapNeutral

Annual balance sheet for OK Biotech Co, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	567	645	637	365	291
Net Total Accounts Receivable
Net Total Receivables	306	405	409	489	588
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	1,276	1,489	1,527	1,317	1,473
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	636	664	891	1,242	1,653
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	2,535	2,813	3,061	3,067	3,695
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	653	701	828	578	745
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	806	1,108	1,217	670	1,203
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	1,729	1,705	1,845	2,398	2,492
Total Liabilities & Shareholders' Equity	2,535	2,813	3,061	3,067	3,695
Total Common Shares Outstanding